|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
4.09/4.76
|
Enterprise Value
4.80B
|
Balance Sheet |
Book Value Per Share
33.92
|
Cash Flow |
Cash Flow Yield
0.07
|
Income Statement |
Total Revenue
1.13B
|
Operating Revenue Per Share
19.04
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/09/21 06:42 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |